TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Pharma Inc AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
207,465
|
179,467
|
192,736 |
Financial expenses |
47,207
|
24,311
|
7,453 |
Earnings before taxes |
44,745
|
52,099
|
61,563 |
Total assets |
481,574
|
430,455
|
366,384 |
Current assets |
166,103
|
131,644
|
112,223 |
Current liabilities |
29,969
|
57,539
|
45,523 |
Equity capital |
277,035
|
234,857
|
180,806 |
- share capital |
29,504
|
28,617
|
26,640 |
Employees (average) | 32 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
57.5%
|
54.6%
|
49.3% |
Turnover per employee | 6,023 | ||
Profit as a percentage of turnover |
21.6%
|
29.0%
|
31.9% |
Return on assets (ROA) |
19.1%
|
17.8%
|
18.8% |
Current ratio |
554.2%
|
228.8%
|
246.5% |
Return on equity (ROE) |
16.2%
|
22.2%
|
34.0% |
Change turnover |
22,438
|
-27,573
|
51,235 |
Change turnover % |
12%
|
-13%
|
36% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.